m 16209 has been researched along with sorbinil in 2 studies
| Studies (m 16209) | Trials (m 16209) | Recent Studies (post-2010) (m 16209) | Studies (sorbinil) | Trials (sorbinil) | Recent Studies (post-2010) (sorbinil) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 500 | 44 | 43 |
| Protein | Taxonomy | m 16209 (IC50) | sorbinil (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 5.05 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.8698 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.5 | |
| Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | 5.1333 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 1.3166 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.04 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 1.7292 | |
| Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | 2.95 | |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | 0.8845 | |
| Aldo-keto reductase family 1 member B1 | Sus scrofa (pig) | 1.1 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, K; Miwa, I; Mizota, M; Nakayama, K; Okuda, J | 1 |
| Hashimoto, K; Kato, K; Miwa, I; Mizota, M; Murakami, N; Ohta, M; Okuda, J | 1 |
2 other study(ies) available for m 16209 and sorbinil
| Article | Year |
|---|---|
Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
Topics: Aldehyde Reductase; Animals; Benzofurans; Cataract; Cattle; Diabetic Neuropathies; Hydantoins; Imidazoles; Imidazolidines; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Rhodanine; Sorbitol; Thiazolidines | 1991 |
Acceleration of glycolysis in erythrocytes by the antidiabetic agent M16209.
Topics: Aldehyde Reductase; Animals; Benzofurans; Erythrocytes; Glucose; Glyceraldehyde; Glycolysis; Humans; Hydantoins; Hypoglycemic Agents; Imidazoles; Imidazolidines; In Vitro Techniques; Lactic Acid; Male; Phosphofructokinase-1; Rats; Rats, Wistar; Tolbutamide | 1996 |